GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
6NE2 | 6NE2 | Designed repeat protein in complex with Fz7 | |
6NE1 | 6NE1 | Designed repeat protein in complex with Fz4 | |
6NC3 | 6NC3 | AMC011 v4.2 SOSIP Env trimer in complex with fusion peptide targeting antibody VRC34 fragment antigen binding | HIV-1 Env AMC011 v4.2 SOSIP gp120, HIV-1 Env AMC011 v4.2 SOSIP gp41, Monoclonal antibody VRC34.01 fragment antigen binding heavy chain, Monoclonal antibody VRC34.01 fragment antigen binding light chain |
6NC2 | 6NC2 | AMC011 v4.2 SOSIP Env trimer in complex with fusion peptide targeting antibody ACS202 fragment antigen binding | AMC011 v4.2 SOSIP gp120, AMC011 v4.2 SOSIP gp41, Monoclonal antibody ACS202 fragment antigen binding heavy chain, Monoclonal antibody ACS202 fragment antigen binding kappa chain |
6NB7 | 6NB7 | SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2) | Spike glycoprotein, S230 heavy chain, S230 light chain |
6NB6 | 6NB6 | SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1) | Spike glycoprotein, S230 heavy chain, S230 light chain |
6NB4 | 6NB4 | MERS-CoV S complex with human neutralizing LCA60 antibody Fab fragment (state 2) | Spike glycoprotein, LCA60 heavy chain, LCA60 light chain |
6NB3 | 6NB3 | MERS-CoV complex with human neutralizing LCA60 antibody Fab fragment (state 1) | Spike glycoprotein, LCA60 light chain, LCA60 heavy chain |
6NAE | 6NAE | Crystal Structure of Ebola zaire GP protein with bound ARN0074898 | |
6NAE | 6NAE | Crystal Structure of Ebola zaire GP protein with bound ARN0074898 | |
6N9T | 6N9T | Structure of a peptide-based photo-affinity cross-linker with Herceptin Fc | Immunoglobulin G1 FC, Photo-affinity peptide |
6N6B | 6N6B | The complex crystal structure of neuraminidase from A/Minnesota/11/2010 with B10 antibody. | Neuraminidase (E.C.3.2.1.18), B10 antibody Heavy Chain Fab, B10 antibody Light Chain Fab |
6N5E | 6N5E | Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope | |
6N5B | 6N5B | Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope | antibody heavy chain, antibody light chain, Hemagglutinin |
6N51 | 6N51 | Metabotropic Glutamate Receptor 5 bound to L-quisqualate and Nb43 | Metabotropic glutamate receptor 5, Nanobody 43 |
6N50 | 6N50 | Metabotropic Glutamate Receptor 5 Extracellular Domain in Complex with Nb43 and L-quisqualic acid | |
6N4Y | 6N4Y | Metabotropic Glutamate Receptor 5 Extracellular Domain with Nb43 | |
6N35 | 6N35 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
6N35 | 6N35 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
6N2X | 6N2X | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
6N2X | 6N2X | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
6N1W | 6N1W | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain |
6N1V | 6N1V | Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | 17D4 Heavy chain, 17D4 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 Heavy chain, PGT122 Light chain, VRC03 Heavy chain, VRC03 Light chain |
6MZJ | 6MZJ | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 2 Fabs bound, sharpened map | 426c DS-SOSIP D3, VRC01GL light chain, VRC01GL heavy chain |
6MZJ | 6MZJ | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 2 Fabs bound, sharpened map | 426c DS-SOSIP D3, VRC01GL light chain, VRC01GL heavy chain |
6MYY | 6MYY | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 3 Fabs bound, sharpened map | 426c DS-SOSIP D3, VRC01GL light chain, VRC01GL heavy chain |
6MYY | 6MYY | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 3 Fabs bound, sharpened map | 426c DS-SOSIP D3, VRC01GL light chain, VRC01GL heavy chain |
6MYV | 6MYV | Sialidase26 co-crystallized with DANA-Gc | |
6MYA | 6MYA | Crystal structure of InvbP.18715.a.KN11: Influenza hemagglutinin from strain A/Almaty/32/1998 | |
6MWR | 6MWR | Recognition of MHC-like molecule | |
6MVL | 6MVL | Crystal structure of VISTA bound to a pH-selective antibody Fab fragment | V-type immunoglobulin domain-containing suppressor of T-cell activation, Antibody Fab fragment heavy chain, Antibody Fab fragment light chain |
6MUG | 6MUG | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MUF | 6MUF | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MUB | 6MUB | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
6MUB | 6MUB | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
6MU8 | 6MU8 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MU7 | 6MU7 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MU6 | 6MU6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
6MTN | 6MTN | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MTJ | 6MTJ | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
6MSU | 6MSU | Integrin alphaVBeta3 in complex with EETI-II 2.5F | |
6MSS | 6MSS | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | A11B8.2 NKT TCR alpha-chain, A11B8.2 NKT TCR beta-chain, Antigen-presenting glycoprotein CD1d1, Beta-2-microglobulin |
6MSL | 6MSL | Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D | |
6MRV | 6MRV | Sialidase26 co-crystallized with DANA | |
6MPH | 6MPH | Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain |
6MPG | 6MPG | Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024